INDOCONSEIndoco Remedies Limited· PharmaceuticalsMinimalNeutral
Announced Fri, 8 May · 12:32 IST

Indoco Remedies Limited has informed the Exchange about Copy of Newspaper Publication

INDOCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-11.7%1-day move
₹246.80
prior close
₹233.50
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-0.0-0.0-0.5-11.7-11.6-8.4-8.9-8.8-13.5-14.5-19.6+1.3
Up moveDown movePending
AI summary

Indoco Remedies Limited has notified the exchanges about publishing its audited standalone and consolidated financial results for Q4 and full year ended 31st March 2026. The results were published on 8th May 2026 in Business Standard (All India editions) and Mumbai Lakshadeep (Marathi newspaper) as required under SEBI regulations. This is a mandatory disclosure under Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The actual financial figures are not included in this notification letter.

Likely market impact

This filing confirms that Indoco Remedies has published its FY2026 annual and Q4 results in newspapers, meeting regulatory compliance requirements. The actual profit/loss figures and performance details would be in the published advertisements or the separate full results filing.